Keywords: Parkinson's Disease, Multi-Contrast
Motivation: Cortical myelination (CM) has not been explored as a biomarker for predicting freezing of gait (FoG) or differentiating Parkinson’s disease (PD) subtypes, despite the limited accessibility of current neuroimaging techniques for FoG study.
Goal(s): This study investigates CM differences across PD-FoG, PD-Non-FoG, and HC, aiming to correlate CM with clinical metrics of motor impairment and disease progression.
Approach: Using T1/T2-weighted MRI, we analyzed hemispheric-specific CM to identify their variations and associations with clinical and physical therapy metrices.
Results: We found reduced CM in PD-FoG, especially in motor-related regions, with CM levels correlating positively with motor severity and disease progression.
Impact: Cortical myelination reduction correlated with clinical and PT scores, suggests CM as a useful biomarker in settings needing detailed symptom tracking. CM could guide interventions, preserving mobility and reducing fall risks in severe PD-FoG cases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords